Navigation Links
Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/21/2009

MOUNTAIN VIEW, Calif., July 21 /PRNewswire/ -- Howard Rosenberg, M.D., a board-certified plastic surgeon and Medical Director at Accent on Aesthetics Plastic Surgery Medical Center, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines. Dr. Rosenberg has treated more than fifty patients with Artefill due to its proven success and effectiveness for the long lasting correction of wrinkles.

Dr. Rosenberg commented, "Artefill is a product we have consistently recommended to our patients who are looking for a dermal filler that lasts longer and doesn't require repeat injections. We believe we have had great success with the product over the past few years as it's easy to administer and the patient experience is similar to temporary fillers on the market today."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Northern California and is not available at all physician offices. Dr. Rosenberg is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

Stephanie C., a patient of Dr. Rosenberg's said, "I am delighted with the results of Artefill that I just received and will be returning for even more."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

About Accent on Aesthetics Plastic Surgery Medical Center:

As Medical Director of Accent on Aesthetics Plastic Surgery Medical Center, Dr. Howard L. Rosenberg is one of the Bay Area's most sought-after experts on cosmetic enhancement. With over two decades of experience, Dr. Rosenberg offers a comprehensive menu of the most advanced surgical and noninvasive procedures available. You can feel confident you have chosen a doctor who can give you the beautiful, natural-looking results you want. You'll also appreciate his warmth and sensitivity - with Dr. Rosenberg as your doctor, you will always feel valued, appreciated and well cared for. For more information visit http://www.accentonaesthetics.com/.

ATTENTION MEDIA: To download Artefill patient before and after pictures visit http://www.artefill.com/content/c/beforeandafter/overview.asp.

    Contact:
    Dr. Howard L. Rosenberg, MD, FACS
    Accent on Aesthetics Plastic Surgery Medical Center
    650-961-2652


'/>"/>
SOURCE Accent on Aesthetics Plastic Surgery Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
2. New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
3. Plastic Surgeons Warn of Malnutrition in Body Contouring Patients
4. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
6. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
7. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
8. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
9. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Shoulder Surgery Doesnt Prevent Return to Sports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):